These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 18826299

  • 21. A novel approach to oral delivery of insulin by conjugating with low molecular weight chitosan.
    Lee E, Lee J, Jon S.
    Bioconjug Chem; 2010 Oct 20; 21(10):1720-3. PubMed ID: 20849099
    [Abstract] [Full Text] [Related]

  • 22. [Solubilizing and sustained-releasing abilities and safety preliminary evaluation for paclitaxel based on N-octyl-O, N-carboxymethyl chitosan polymeric micelles].
    Huo MR, Zhang Y, Zhou JP, Lü L, Liu H, Liu FJ.
    Yao Xue Xue Bao; 2008 Aug 20; 43(8):855-61. PubMed ID: 18956780
    [Abstract] [Full Text] [Related]

  • 23. Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel.
    Khandare JJ, Jayant S, Singh A, Chandna P, Wang Y, Vorsa N, Minko T.
    Bioconjug Chem; 2006 Aug 20; 17(6):1464-72. PubMed ID: 17105225
    [Abstract] [Full Text] [Related]

  • 24. Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms.
    Clementi C, Miller K, Mero A, Satchi-Fainaro R, Pasut G.
    Mol Pharm; 2011 Aug 01; 8(4):1063-72. PubMed ID: 21608527
    [Abstract] [Full Text] [Related]

  • 25. Development of stabilized Paclitaxel nanocrystals: In-vitro and in-vivo efficacy studies.
    Sharma S, Verma A, Teja BV, Shukla P, Mishra PR.
    Eur J Pharm Sci; 2015 Mar 10; 69():51-60. PubMed ID: 25559064
    [Abstract] [Full Text] [Related]

  • 26. Carboxymethyl-chitosan-tethered lipid vesicles: hybrid nanoblanket for oral delivery of paclitaxel.
    Joshi N, Saha R, Shanmugam T, Balakrishnan B, More P, Banerjee R.
    Biomacromolecules; 2013 Jul 08; 14(7):2272-82. PubMed ID: 23721348
    [Abstract] [Full Text] [Related]

  • 27. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V.
    J Control Release; 2009 Jan 05; 133(1):11-7. PubMed ID: 18950666
    [Abstract] [Full Text] [Related]

  • 28. A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy.
    Shan L, Cui S, Du C, Wan S, Qian Z, Achilefu S, Gu Y.
    Biomaterials; 2012 Jan 05; 33(1):146-62. PubMed ID: 21959006
    [Abstract] [Full Text] [Related]

  • 29. New active paclitaxel amino acids derivatives with improved water solubility.
    Paradis R, Pagé M.
    Anticancer Res; 1998 Jan 05; 18(4A):2711-6. PubMed ID: 9703933
    [Abstract] [Full Text] [Related]

  • 30. Antiangiogenic antitumor activity of HPMA copolymer-paclitaxel-alendronate conjugate on breast cancer bone metastasis mouse model.
    Miller K, Eldar-Boock A, Polyak D, Segal E, Benayoun L, Shaked Y, Satchi-Fainaro R.
    Mol Pharm; 2011 Aug 01; 8(4):1052-62. PubMed ID: 21545170
    [Abstract] [Full Text] [Related]

  • 31. Synergistic anti-tumor activity of paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel in vitro and in vivo.
    Guo DD, Xu CX, Quan JS, Song CK, Jin H, Kim DD, Choi YJ, Cho MH, Cho CS.
    Biomaterials; 2009 Sep 01; 30(27):4777-85. PubMed ID: 19524293
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel.
    McConathy WJ, Nair MP, Paranjape S, Mooberry L, Lacko AG.
    Anticancer Drugs; 2008 Feb 01; 19(2):183-8. PubMed ID: 18176115
    [Abstract] [Full Text] [Related]

  • 33. Development of drug-loaded chitosan hollow nanoparticles for delivery of paclitaxel to human lung cancer A549 cells.
    Jiang J, Liu Y, Wu C, Qiu Y, Xu X, Lv H, Bai A, Liu X.
    Drug Dev Ind Pharm; 2017 Aug 01; 43(8):1304-1313. PubMed ID: 28402175
    [Abstract] [Full Text] [Related]

  • 34. In vitro evaluation on novel modified chitosan for targeted antitumor drug delivery.
    Qu D, Lin H, Zhang N, Xue J, Zhang C.
    Carbohydr Polym; 2013 Jan 30; 92(1):545-54. PubMed ID: 23218334
    [Abstract] [Full Text] [Related]

  • 35. Single-drug multiligand conjugates: synthesis and preliminary cytotoxicity evaluation of a paclitaxel-dipeptide "scorpion" molecule.
    Safavy A, Raisch KP, Matusiak D, Bhatnagar S, Helson L.
    Bioconjug Chem; 2006 Jan 30; 17(3):565-70. PubMed ID: 16704191
    [Abstract] [Full Text] [Related]

  • 36. Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity.
    Lee H, Lee K, Park TG.
    Bioconjug Chem; 2008 Jun 30; 19(6):1319-25. PubMed ID: 18481885
    [Abstract] [Full Text] [Related]

  • 37. Polylysine and cysteine functionalized chitosan nanoparticle as an efficient platform for oral delivery of paclitaxel.
    Du X, Yin S, Xu L, Ma J, Yu H, Wang G, Li J.
    Carbohydr Polym; 2020 Feb 01; 229():115484. PubMed ID: 31826482
    [Abstract] [Full Text] [Related]

  • 38. Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.
    Shimada T, Ueda M, Jinno H, Chiba N, Wada M, Watanabe J, Ishihara K, Kitagawa Y.
    Anticancer Res; 2009 Apr 01; 29(4):1009-14. PubMed ID: 19414339
    [Abstract] [Full Text] [Related]

  • 39. Specific renal uptake of randomly 50% N-acetylated low molecular weight chitosan.
    Yuan ZX, Zhang ZR, Zhu D, Sun X, Gong T, Liu J, Luan CT.
    Mol Pharm; 2009 Apr 01; 6(1):305-14. PubMed ID: 19035784
    [Abstract] [Full Text] [Related]

  • 40. Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors.
    Rivkin I, Cohen K, Koffler J, Melikhov D, Peer D, Margalit R.
    Biomaterials; 2010 Sep 01; 31(27):7106-14. PubMed ID: 20619792
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.